Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 EUR | +2.70% | -6.28% | -46.17% |
Apr. 04 | AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada | MT |
Apr. 03 | AB Science: reconsideration possible for masitinib in ALS | CF |
- Stock Market
- Equities
- AB Stock
- A8D Stock
- News AB Science